Webinar | October 3, 2024

Mastering The Art Of Developing A Successful Bispecific Antibody

Source: Abzena

Shifting from single-function antibodies to complex bispecific designs presents unique challenges that require innovative approaches. Unlike conventional antibodies, bispecifics demand customized screening strategies to pinpoint the most effective format.

This in-depth webinar explores the key principles and best practices for designing successful bispecific antibodies. In it, Dr. Timothy Wood, Ph.D., Senior Scientist at Abzena focuses on intelligent bispecific design, with a particular emphasis on factors such as avidity, spacing, and the configuration of fragment antigen binding (Fab) and single-chain fragment variable (scFv) arms. Our systematic approach aims to streamline the screening process, enabling broad exploration while keeping designs efficient and minimal.

Attendees will learn:

  • Key Design Considerations for Bispecific Candidates: Learn which elements to incorporate or avoid to optimize your bispecific antibody designs.
  • Single-Step Purification for Enhanced Purity: Discover effective methods for improving antibody purity through efficient single-step purification processes.
  • In-Depth Case Study on Screening Strategies: Gain valuable insights into the importance of screening multiple designs, supported by a detailed case study.

This webinar offers practical guidance for anyone involved in the development of bispecific antibodies, providing the tools needed to address the complexity of this evolving field.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma